Cargando…
Randomized double‐blind clinical studies of ularitide and other vasoactive substances in acute decompensated heart failure: a systematic review and meta‐analysis
AIMS: Acute decompensated heart failure (ADHF) has a poor prognosis and limited treatment options. No direct comparisons between ularitide—a synthetic natriuretic peptide being evaluated in ADHF—and other vasoactive substances are available. The aim of this meta‐analysis was to determine haemodynami...
Autores principales: | Mitrovic, Veselin, Forssmann, Wolf‐Georg, Schnitker, Jan, Felix, Stephan B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300812/ https://www.ncbi.nlm.nih.gov/pubmed/30246939 http://dx.doi.org/10.1002/ehf2.12349 |
Ejemplares similares
-
Ularitide for the treatment of acute decompensated heart failure: from preclinical to clinical studies
por: Anker, Stefan D., et al.
Publicado: (2015) -
Involvement of vasoactive substances in hemodynamics
disturbances in cirrhosis
por: Grancea-Iancu, M
Publicado: (2014) -
A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure
por: Ponikowski, Piotr, et al.
Publicado: (2014) -
Decompensated heart failure
por: Mangini, Sandrigo, et al.
Publicado: (2013) -
Iatrogenic Decompensated Heart Failure
por: Tran, Patrick, et al.
Publicado: (2020)